Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 14-23

  Naz, Sarwat ^a   Bashir, Mohsin ^a   Ranganathan, Prathibha ^a   Bodapati, Priyanka ^a   Santosh, Vani ^b   Kondaiah, Paturu ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM BINDING PROTEIN; PA1 1 PROTEIN; PROTEIN; PROTEIN KINASE B; PROTEIN S100A2; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CARCINOGENIC ACTIVITY; CELL INTERACTION; CELL INVASION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTUMORIGENIC ACTION; REGULATORY MECHANISM; TUMOR GROWTH; TUMOR PROMOTION; TUMOR XENOGRAFT;

ANIMALS; CALCIUM; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTACTIC FACTORS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE, NUDE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-AKT; S100 PROTEINS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891350131     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt287     Document Type: Article

References (45)

1. Salama,I. et al. (2008) A review of the S100 proteins in cancer. Eur. J. Surg. Oncol., 34, 357-364.
2. Emberley,E.D. et al. (2004) S100 proteins and their influence on pro-survival pathways in cancer. Biochem. Cell Biol., 82, 508-515.
3. Mishra,S.K. et al. (2012) S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev., 31, 163-172.
4. Lukanidin,E. et al. (2012) Building the niche: the role of the S100 proteins in metastatic growth. Semin. Cancer Biol., 22, 216-225.
5. Harpio,R. et al. (2004) S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clin. Biochem., 37, 512-518.
6. Wolf,S. et al. (2011) S100A2 in cancerogenesis: a friend or a foe? Amino Acids, 41, 849-861.
7. Melle,C. et al. (2008) Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11. PLoS One, 3, e3767.
8. Wicki,R. et al. (1997) Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium, 22, 243-254.
9. McKiernan,E. et al. (2011) The role of S100 genes in breast cancer progression. Tumour Biol., 32, 441-450.
10. Bulk,E. et al. (2009) S100A2 induces metastasis in non-small cell lung cancer. Clin. Cancer Res., 15, 22-29.
11. Hough,C.D. et al. (2001) Coordinately up-regulated genes in ovarian cancer. Cancer Res., 61, 3869-3876.
12. Xie,R. et al. (2009) S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling. Lab. Invest., 89, 937-947.
13. Villaret,D.B. et al. (2000) Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope, 110(3 Pt 1), 374-381.
14. Hsieh,H.L. et al. (2003) Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays. Biochem. Biophys. Res. Commun., 307, 375-381.
15. Chivu,E.M. et al. (2010) Identification of potential biomarkers for early and advanced gastric adenocarcinoma detection. Hepatogastroenterology, 57, 1453-1464.
16. Yao,R. et al. (2007) Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res., 27(5A), 3051-3058.
17. Jamieson,N.B. et al. (2011) A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma. Ann. Surg. Oncol., 18, 2318-2328.
18. Biankin,A.V. et al.; NSW Pancreatic Cancer Network. (2009) Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer. Gastroenterology, 137, 558-568.
19. Diederichs,S. et al. (2004) S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res., 64, 5564-5569.
20. Naz,S. et al. (2012) Regulation of S100A2 expression by TGF-ß-induced MEK/ERK signalling and its role in cell migration/invasion. Biochem. J., 447, 81-91.
21. Katsuno,Y. et al. (2013) TGF-beta signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol., 25, 76-84.
22. Yu,M. et al. (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science, 339, 580-584.
23. Massagué,J. (2012) TGFß signalling in context. Nat. Rev. Mol. Cell Biol., 13, 616-630.
24. Kalluri,R. et al. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest., 119, 1420-1428.
25. Thompson,E.W. et al. (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res., 65, 5991-5995.
26. Schneider,M. et al. (2008) S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? J. Mol. Med. (Berl)., 86, 507-522.
27. Matsuura,I. et al. (2010) Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness. Biochem. J., 426, 327-335.
28. Ranganathan,P. et al. (2007) Expression profiling of genes regulated by TGF-beta: differential regulation in normal and tumour cells. BMC Genomics, 8, 98.
29. Reddy,S.P. et al. (2008) Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. Clin. Cancer Res., 14, 2978-2987.
30. Tse,J.C. et al. (2007) Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J. Cell. Biochem., 101, 816-829.
31. Larue,L. et al. (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene, 24, 7443-7454.
32. Ogunwobi,O.O. et al. (2012) Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma. J. Gastroenterol. Hepatol., 27, 566-578.
33. Ju,W. et al. (2006) Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol. Cell. Biol., 26, 654-667.
34. Yuan,W. et al. (2001) Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J. Biol. Chem., 276, 38502-38510.
35. Cho,H.J. et al. (2007) Snail is required for transforming growth factor-betainduced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem. Biophys. Res. Commun., 353, 337-343.
36. Jungert,K. et al. (2007) Sp1 is required for transforming growth factor-betainduced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res., 67, 1563-1570.
37. Mueller,A. et al. (2005) The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J. Biol. Chem., 280, 29186-29193.
38. Wang,P. et al. (2009) Dual role of Ski in pancreatic cancer cells: tumorpromoting versus metastasis-suppressive function. Carcinogenesis, 30, 1497-1506.
39. Tsai,W.C. et al. (2006) Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. Mol. Cancer Res., 4, 539-547.
40. De Larco,J.E. et al. (1985) Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype. Proc. Natl Acad. Sci. USA, 82, 5015-5019.
41. Kamikura,D.M. et al. (2000) Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44. Mol. Cell. Biol., 20, 3482-3496.
42. Zeisberg,M. et al. (2009) Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest., 119, 1429-1437.
43. Reka,A.K. et al. (2010) Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial- mesenchymal transition. Mol. Cancer Ther., 9, 3221-3232.
44. Bakin,A.V. et al. (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem., 275, 36803-36810.
45. Lamouille,S. et al. (2011) Emergence of the phosphoinositide 3-kinase-Aktmammalian target of rapamycin axis in transforming growth factor-ß-induced epithelial-mesenchymal transition. Cells. Tissues. Organs, 193, 8-22.